Eradacin

Eradacin - General Information

Eradacin is a quinolone derivative antibiotic for the treatment of bacterial infection of respiratory tract, urinary tract, GI, CNS and immuno compromised patients. Eradacin is known to be effective against penicillin resistant strains and is a single dose orally administered drug, which avoids all complications of parenteral administration seen with penicillin, especially anaphylactic shock.

Pharmacology of Eradacin

Eradacin is a nonfluorinated quinolone antibiotic. Its mode of action depends on blocking of bacterial DNA replication by binding itself to an enzyme called DNA gyrase, which allows the untwisting required to replicate one DNA double helix into two. Eradacin is a broad-spectrum antibiotic that is active against both Gram-positive and Gram-negative bacteria.

Additional information about Eradacin

Eradacin Indication: For the treatment of bacterial infection of respiratory tract, urinary tract, GI, CNS and immuno compromised patients.
Mechanism Of Action: Eradacin binds to and inhibits the enzymes topoisomerase II (DNA gyrase) and topoisomerase IV, which are required for bacterial DNA replication, transcription, repair, and recombination.
Drug Interactions: Not Available
Food Interactions: Not Available
Generic Name: Rosoxacin
Synonyms: ROS; Rosoxacino [Inn-Spanish]; Rosoxacine [Inn-French]; Acrosoxacin
Drug Category: Anti-Infective Agents
Drug Type: Small Molecule; Approved

Other Brand Names containing Rosoxacin: Eracine; Eradacil; Eradacin; Roxadyl; Winuron;
Absorption: Not Available
Toxicity (Overdose): Not Available
Protein Binding: Not Available
Biotransformation: Not Available
Half Life: Not Available
Dosage Forms of Eradacin: Not Available
Chemical IUPAC Name: 1-ethyl-4-oxo-7-pyridin-4-ylquinoline-3-carboxylic acid
Chemical Formula: C17H14N2O3
Rosoxacin on Wikipedia: Not Available
Organisms Affected: Enteric bacteria and other eubacteria